AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 5 analysts with an average price target of $11.15. This is a potential upside of $4.31 (63.01%) from yesterday's end of day stock price of $6.84.

Aquestive Therapeutics's activity chart (see below) currently has 90 price targets and 88 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.32% with an average time for these price targets to be met of 180.5 days.

Highest price target for AQST is $12, Lowest price target is $7, average price target is $9.

Most recent stock forecast was given by JASON BUTLER from JMP on 08-Oct-2025. First documented stock forecast 19-Aug-2018.

Currently out of the existing stock ratings of AQST, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$12

$4.92 (69.49%)

$9

16 days ago
(08-Oct-2025)

0/11 (0%)

$5.31 (79.37%)

Buy

$8

$0.92 (12.99%)

$12

1 months 17 days ago
(07-Sep-2025)

0/3 (0%)

$2.99 (59.68%)

Buy

$10

$2.92 (41.24%)

$10

4 months 8 days ago
(16-Jun-2025)

9/30 (30%)

$6.65 (198.51%)

323

Buy

$7

$-0.08 (-1.13%)

$9

4 months 23 days ago
(01-Jun-2025)

6/7 (85.71%)

$4.19 (149.11%)

238

Buy

$8

$0.92 (12.99%)

$10

7 months 18 days ago
(06-Mar-2025)

2/8 (25%)

$5.35 (201.89%)

265

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 180.5 days on average for the stock forecasts to be realized with a an average price target met ratio 23.32

Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?

THOMAS FLATEN

Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Thomas Flaten works at LAKE STREET and has 1 price targets and 2 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Jason Butler with highest potential upside - $4.92

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Gary Nachman with lowest potential downside - -$0.08

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?